TICADAX 60MG (Ticagrelor (60mg))

Ticadax 60mg Tablet is classified as an antiplatelet agent, commonly referred to as a blood thinner. Its primary function is to diminish the development of dangerous blood clots within blood vessels, thereby aiding in the prevention of heart attacks and strokes in individuals diagnosed with heart conditions. This medication is also indicated for those who have recently experienced a heart attack or suffer from severe chest pain related to heart issues, specifically unstable angina, particularly after a stent procedure. By preserving the patency of stents and reducing the incidence of subsequent heart attacks and strokes, Ticadax plays a crucial role in cardiovascular management. It is often prescribed alongside aspirin, which serves as an additional antiplatelet treatment. Patients can take Ticadax 60mg with or without food, but it is essential to follow a consistent daily routine for administration. Continuation of therapy is vital, even when feeling well, since discontinuation could elevate the risk of future cardiovascular events. Commonly observed adverse effects include breathlessness and increased bleeding tendencies. Should bleeding occur, it may take longer to cease than normal, though most instances are mild and self-limiting. Persistent bleeding or worsening breathlessness should warrant a consultation with a healthcare provider. Additionally, Ticadax is contraindicated in individuals experiencing any form of bleeding, such as from a stomach ulcer or intracranial hemorrhage, and it is not advisable for those with liver conditions. Prior to initiating treatment with Ticadax, patients should disclose any relevant medical history to their healthcare provider.